急性膵炎の市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート収録範囲製品別（投薬、診断、その他）、原因別（胆石、アルコール中毒、遺伝子疾患、感染症、その他）、エンドユーザー別（病院、診断研究所、外来手術センター、その他）、地域別（北米、欧州、アジア太平洋地域、南米＆中米、中東＆アフリカ地域）

Acute Pancreatitis Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa)

急性膵炎の市場規模は、2022年の56億4,977万米ドルから2030年には88億2,737万米ドルに達すると予測され、2022年から2030年までの年平均成長率は5.7％を記録すると推定される。膵臓は、血糖値を調節するホルモ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年9月8日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	196	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

急性膵炎の市場規模は、2022年の56億4,977万米ドルから2030年には88億2,737万米ドルに達すると予測され、2022年から2030年までの年平均成長率は5.7％を記録すると推定される。

膵臓は、血糖値を調節するホルモンであるインスリンを産生する。膵炎は膵臓のインスリン産生細胞を傷つけ、急性膵炎に罹患した患者に糖尿病を引き起こす。急性膵炎に罹患している人は、一般の人に比べて糖尿病のリスクが2倍高い。世界保健機関（WHO）アメリカ糖尿病学会は、急性膵炎後の糖尿病の発症を膵外分泌性糖尿病（膵原性糖尿病）に分類している。膵原性糖尿病は、膵外分泌障害と関連することが多くなってきている。糖尿病の後遺症は急性膵炎の重症度範囲にわたって観察され、他の臨床合併症を伴うこともある。

2022年に発表されたEuropean Review for Medical and Pharmacological Sciencesによれば、欧米の糖尿病患者集団における膵原性糖尿病の有病率は5〜10％であり、急性膵炎が80％を引き起こすのに対し、慢性膵炎が20％を占める。2021年にNational Library of Medicineに掲載された論文によると、急性膵炎患者の〜23％が退院後3年以内に糖尿病を発症する可能性が高い。さらに、2020年にJournal of Gastroenterology誌に発表された論文によると、急性膵炎後、退院後6ヶ月、12ヶ月、18ヶ月、24ヶ月の時点で、それぞれ〜3%、7%、9%、11%の患者が糖尿病を発症する。MDPIに掲載された論文によると、2023年には急性膵炎患者の〜40％が糖尿病予備軍や糖尿病に罹患しており、2型糖尿病患者よりも死亡や再入院のリスクが高い。さらに、成人患者の〜60.2％が急性膵炎後に糖尿病を発症し、小児の9％が急性再発性膵炎後または慢性膵炎後に糖尿病を発症し、このリスクは成人期になるにつれて増加する。研究者らは、重症急性膵炎と軽症急性膵炎を比較したメタアナリシスにおいて、重症急性膵炎後の糖尿病発症率（〜39％）が軽症急性膵炎後（14％）よりも高いことを指摘している。

中国の調査研究によると、高トリグリセリド血症（HTG）がアルコールを抜いて急性膵炎の第2位の原因になっている。患者の約29％が再発性急性膵炎（RAP）を経験し、その44.6％が高トリグリセリド血症を病因としていた。2023年6月にBiomed Central誌に発表された論文では、HTGは急性膵炎の重症度と再発の重要な独立した危険因子であると述べられている。このように、急性膵炎に罹患または回復した患者における糖尿病の発生率の増加は、急性膵炎市場の成長に寄与している。

急性膵炎市場は製品とエンドユーザーに区分される。提供物に基づき、急性膵炎市場は投薬、診断、その他に区分される。2022年には、診断セグメントが最大のシェアを占めている。さらに、その他セグメントは予測期間中（2022-2030年）に最も速いCAGRを記録すると予測されている。診断セグメントの急性膵炎市場は、さらに血液検査、CTスキャン、便検査、超音波検査、MRI、尿検査に区分される。原因に基づき、急性膵炎市場は胆石、アルコール中毒、遺伝性疾患、感染症、その他に分類される。2022年には、胆石セグメントが市場で最大のシェアを占めた。同セグメントは予測期間中（2022-2030年）に最も高いCAGR率を記録すると予測されている。エンドユーザーに基づき、急性膵炎市場は病院、診断研究所、外来手術センター、その他に分類される。2022年には、病院セグメントが市場で最大のシェアを占めた。診断検査室セグメントの急性膵炎市場は、予測期間（2022-2030年）にCAGR 6.4％で成長すると推定される。

地域別では、北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分される。北米のフリージオンは急性膵炎市場で最大の市場シェアを占めている。北米の急性膵炎市場は、胆石症例数の増加やアルコールの過剰摂取による疾病負担の増加により成長が見込まれている。また、医療施設の技術進歩も北米の急性膵炎市場に利益をもたらしている。米国では、アルコール摂取の広範な習慣と胆石症例の急増により、急性膵炎症例数が増加している。APACは2022年から2030年にかけて最も高い成長率を記録すると予想されている。APACの市場成長は、膵炎症例の増加、膵炎の治療法を開発する研究者、国民の意識を高めるための政府の取り組みなどの要因によるものである。また、アルコール関連膵炎の症例も同地域の市場成長を後押ししている。

経済協力開発機構（OECD）、疾病管理予防センター（CDC）、欧州連合（EU）、米国国立衛生研究所（NIH）は、急性膵炎市場に関する報告書を作成する際に参照したいくつかの主要な一次および二次情報源である。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Acute Pancreatitis Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Acute Pancreatitis Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Acute Pancreatitis Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. Acute Pancreatitis Market - Global Market Analysis
6.1 Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. Global Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings
7.1 Overview
7.2 Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Global Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes
8.1 Overview
8.2 Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. Acute Pancreatitis Market - Geographical Analysis
10.1 North America Acute Pancreatitis Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.3.1 North America: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.3.2 North America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.4 North America: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.5 North America: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.5.1 North America Acute Pancreatitis Market, by Country
10.1.5.2 US
10.1.5.2.1 Overview
10.1.5.2.2 US Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.2.3 US: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.5.2.3.1 US: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.5.2.3.2 US: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.5.2.4 US: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.5.2.5 US: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Overview
10.1.5.3.2 Canada Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.3.3 Canada: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.5.3.3.1 Canada: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.5.3.3.2 Canada: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.5.3.4 Canada: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.5.3.5 Canada: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Overview
10.1.5.4.2 Mexico Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.4.3 Mexico: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.5.4.3.1 Mexico: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.5.4.3.2 Mexico: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.5.4.4 Mexico: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.5.4.5 Mexico: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2 Europe Acute Pancreatitis Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.3.1 Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.3.2 Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.4 Europe: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5 Europe: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.1 Europe Acute Pancreatitis Market, by Country
10.2.5.2 UK
10.2.5.2.1 Overview
10.2.5.2.2 UK Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.2.3 UK: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.2.3.1 UK: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.2.3.2 UK: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.2.4 UK: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.2.5 UK: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.3 Germany
10.2.5.3.1 Overview
10.2.5.3.2 Germany Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.3.3 Germany: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.3.3.1 Germany: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.3.3.2 Germany: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.3.4 Germany: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.3.5 Germany: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.4 France
10.2.5.4.1 Overview
10.2.5.4.2 France Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.4.3 France: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.4.3.1 France: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.4.3.2 France: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.4.4 France: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.4.5 France: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.5 Italy
10.2.5.5.1 Overview
10.2.5.5.2 Italy Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.5.3 Italy: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.5.3.1 Italy: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.5.3.2 Italy: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.5.4 Italy: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.5.5 Italy: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.6 Spain
10.2.5.6.1 Overview
10.2.5.6.2 Spain Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.6.3 Spain: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.6.3.1 Spain: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.6.3.2 Spain: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.6.4 Spain: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.6.5 Spain: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.7 Nordic Region
10.2.5.7.1 Overview
10.2.5.7.2 Nordic Region Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.7.3 Nordic Region: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.7.3.1 Nordic Region: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.7.3.2 Nordic Region: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.7.4 Nordic Region: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.7.5 Nordic Region: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.8 Netherlands
10.2.5.8.1 Overview
10.2.5.8.2 Netherlands Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.8.3 Netherlands: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.8.3.1 Netherlands: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.8.3.2 Netherlands: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.8.4 Netherlands: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.8.5 Netherlands: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.2.5.9 Rest of Europe
10.2.5.9.1 Overview
10.2.5.9.2 Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.2.5.9.3 Rest of Europe: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.2.5.9.3.1 Rest of Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.2.5.9.3.2 Rest of Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.2.5.9.4 Rest of Europe: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.2.5.9.5 Rest of Europe: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3 Asia Pacific Acute Pancreatitis Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.3.2 Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.1 Asia Pacific Acute Pancreatitis Market, by Country
10.3.5.2 China
10.3.5.2.1 Overview
10.3.5.2.2 China Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.2.3 China: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.2.3.1 China: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.2.3.2 China: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.2.4 China: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.2.5 China: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.3 Japan
10.3.5.3.1 Overview
10.3.5.3.2 Japan Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.3.3 Japan: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.3.3.1 Japan: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.3.3.2 Japan: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.3.4 Japan: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.3.5 Japan: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.4 India
10.3.5.4.1 Overview
10.3.5.4.2 India Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.4.3 India: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.4.3.1 India: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.4.3.2 India: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.4.4 India: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.4.5 India: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.5 Australia
10.3.5.5.1 Overview
10.3.5.5.2 Australia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.5.3 Australia: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.5.3.1 Australia: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.5.3.2 Australia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.5.4 Australia: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.5.5 Australia: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.6 South Korea
10.3.5.6.1 Overview
10.3.5.6.2 South Korea Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.6.3 South Korea: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.6.3.1 South Korea: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.6.3.2 South Korea: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.6.4 South Korea: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.6.5 South Korea: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.3.5.7 Rest of Asia Pacific
10.3.5.7.1 Overview
10.3.5.7.2 Rest of Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.3.5.7.3 Rest of Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.3.5.7.3.1 Rest of Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.3.5.7.3.2 Rest of Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.3.5.7.4 Rest of Asia Pacific: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.3.5.7.5 Rest of Asia Pacific: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.4 Middle East & Africa Acute Pancreatitis Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.4.3.2 Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.4.5.1 Middle East & Africa Acute Pancreatitis Market, by Country
10.4.5.2 Saudi Arabia
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.2.3 Saudi Arabia: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.4.5.2.3.2 Saudi Arabia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.4.5.3 UAE
10.4.5.3.1 Overview
10.4.5.3.2 UAE Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.3.3 UAE: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.4.5.3.3.1 UAE: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.4.5.3.3.2 UAE: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.4.5.3.4 UAE: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.4.5.3.5 UAE: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.4.5.4 South Africa
10.4.5.4.1 Overview
10.4.5.4.2 South Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.4.3 South Africa: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.4.5.4.3.1 South Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.4.5.4.3.2 South Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.4.5.4.4 South Africa: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.4.5.4.5 South Africa: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.4.5.5 Rest of Middle East & Africa
10.4.5.5.1 Overview
10.4.5.5.2 Rest of Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.5.3 Rest of Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.4.5.5.3.1 Rest of Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.4.5.5.3.2 Rest of Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.4.5.5.4 Rest of Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.4.5.5.5 Rest of Middle East & Africa: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.5 South & Central America Acute Pancreatitis Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.5.3.2 South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.5.4 South & Central America: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.5.5 South & Central America: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.5.5.1 South & Central America Acute Pancreatitis Market, by Country
10.5.5.2 Brazil
10.5.5.2.1 Overview
10.5.5.2.2 Brazil Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.5.5.2.3 Brazil: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.5.5.2.3.1 Brazil: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.5.5.2.3.2 Brazil: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.5.5.2.4 Brazil: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.5.5.2.5 Brazil: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.5.5.3 Argentina
10.5.5.3.1 Overview
10.5.5.3.2 Argentina Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.5.5.3.3 Argentina: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.5.5.3.3.1 Argentina: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.5.5.3.3.2 Argentina: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.5.5.3.4 Argentina: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.5.5.3.5 Argentina: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.5.5.4 Rest of South & Central America
10.5.5.4.1 Overview
10.5.5.4.2 Rest of South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.5.5.4.3 Rest of South & Central America: Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.5.5.4.3.1 Rest of South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.5.5.4.3.2 Rest of South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.5.5.4.4 Rest of South & Central America: Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.5.5.4.5 Rest of South & Central America: Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. Acute Pancreatitis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dynavax Technologies Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Actim Oy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medtronic Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boston Scientific Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Fresenius Kabi AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The acute pancreatitis market size is expected to reach US$ 8,827.37 million by 2030 from US$ 5,649.77 million in 2022; it is estimated to record a CAGR of 5.7% from 2022 to 2030.

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. The World Health Organization (WHO) American Diabetes Association has classified the development of diabetes after acute pancreatitis as exocrine pancreatic diabetes (pancreatogenic diabetes). Pancreatogenic diabetes is increasingly being linked to exocrine disorders of the pancreas. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5–10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes, and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis.

A Chinese research study suggests that hypertriglyceridemia (HTG) has outpaced alcohol to become the second leading cause of acute pancreatitis. Approximately 29% of patients experience repeated episodes that result in recurrent acute pancreatitis (RAP) and 44.6% of these patients had HTG as an etiological condition. In an article published in Biomed Central in June 2023, HTG has been stated as a significant independent risk factor for the severity and recurrence of acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the acute pancreatitis market.

The acute pancreatitis market is segments into product and end user. Based on offerings, the Acute Pancreatitis Market is segmented into medication, diagnosis, and others. In 2022, the diagnosis segment held the largest share of the market. Moreover, the others segment is expected to record the fastest CAGR during the forecast period (2022-2030). The acute pancreatitis market for the diagnosis segment is further segmented into blood tests, CT scans, stool tests, ultrasound, MRI, and urine tests. Based on causes, the acute pancreatitis market is classified into gallstones, alcoholism, genetic disorders, infection, and others. In 2022, the gallstones segment held the largest share of the market. The same segment is expected to record the highest CAGR rate during the forecast period (2022-2030). Based on end user, the acute pancreatitis market is classified into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market. The acute pancreatitis market for the diagnostic laboratories segment is estimated to grow at a CAGR of 6.4% during the forecast period (2022-2030).

Based on geopgraphy, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North America fregion held the largest market share of the acute pancreatitis market. The acute pancreatitis market in North America is expected to grow due to the increasing burden of the disease with an increase in the number of gallstone cases and excessive consumption of alcohol. Also, technological advancements in healthcare facilities are benefitting the acute pancreatitis market in North America. The US reports an increasingly large number of acute pancreatitis cases due to a wide-scale practice of alcohol consumption and an upsurge in the cases of gallstones. APAC is expected to register the highest growth rate during 2022-2030. The market growth in APAC is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuels the growth of the market in the region.

The Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), European Union, and National Institutes of Health (NIH) are a few key primary and secondary sources referred to while preparing the report on the acute pancreatitis market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（acute）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（acute）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?